Comparing two antibiotics for sepsis in critical illness
Treatments studied
Part of Infections clinical trials.
This trial compares two common antibiotics, meropenem and piperacillin/tazobactam, to see which works better for adults with sepsis who are critically ill. It aims to help doctors choose the best treatment for serious infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have sepsis (a life-threatening infection that causes organ damage) or septic shock
- You are critically ill, needing a breathing machine, high-flow oxygen, or blood pressure support
- You have not already received more than 24 hours of meropenem or piperacillin/tazobactam for this infection
- You are not allergic to penicillin-type antibiotics
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two antibiotics—piperacillin-tazobactam or temocillin—to treat severe ICU infections caused by certain hard-to-treat gut bacteria (ESBL). It may help patients avoid the use of carbapenem antibiotics like meropenem when the bacteria are susceptible.
This trial compares giving a long, continuous infusion versus standard short infusions of certain antibiotics (beta-lactams) to children with sepsis in intensive care. The goal is to find which method works better and is safer.
This study watches how safely two common antibiotics (vancomycin and a combination called piperacillin/tazobactam) work together in hospitalized patients with serious infections. Researchers want to make sure the combination doesn't harm kidney function.
This trial tests a computer tool to help doctors choose the right antibiotic for sepsis early on. It may help improve treatment by providing personalized recommendations based on your condition.
This study looks at different types of sepsis in patients with severe pneumonia. It aims to see how the type of sepsis affects treatment with a common antibiotic called piperacillin/tazobactam.
This trial tests a type of antibiotic called aminoglycosides to treat early sepsis (a serious infection). It is for adults in the hospital who are sick enough to need strong antibiotics but not in the worst stage of the illness.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.